Concepedia

Yinghui Lin

YL

Statistics

Publications

6

Citations

705

H-Index

6

Active since

1992

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Yinghui Lin is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, drug discovery, and drug development.

ORCID

Top concepts

Publications per year

1992–2017

6

Publications

6

MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition

Matthew Fell, Christian Mirescu, Kallol Basu et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 326 citations · Full text

Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity

Jack D. Scott, Duane E. DeMong, Thomas J. Greshock et al. · Journal of Medicinal Chemistry · 2017 · 140 citations · Full text

, , +16

Protein disulfide isomerase activity is released by activated platelets

K Chen, Yinghui Lin, TC Detwiler · Blood · 1992 · 102 citations · Full text

The JAMM motif of human deubiquitinase Poh1 is essential for cell viability

Melissa Gallery, Jonathan L. Blank, Yinghui Lin et al. · Molecular Cancer Therapeutics · 2007 · 74 citations

, , +19

Acne patients frequently associated with abnormal plasma lipid profile

Jiang Hao, Chang Yi Li, Lü Zhou et al. · The Journal of Dermatology · 2015 · 46 citations

, , +11

1–5 of 6